Improving Cytokines and HDL in Diabetic Wistar Rats by Using Combination of Curcumin and Metformin
DOI:
https://doi.org/10.18196/mmjkk.v23i1.17031Keywords:
turmeric, insulin, lipid, cytokinesAbstract
In type 2 diabetes mellitus, lipid profile is often found in the form of high-density lipoprotein (HDL) decrease. TNFa and IL-6 are proinflammatory cytokines that are elevated in the blood in many patients with diabetes mellitus. Turmeric is one of the natural ingredients that have anti-cholesterol and anti-inflammatory effects through the work of its active substance, curcumin. This study aims to evaluate the effect of turmeric extract combined with metformin on HDL, TNFa, and IL-6 levels in diabetic rats. Twenty-four Wistar rats were injected intraperitoneally with streptozotocin and niacinamide. The diabetic rats were divided into control, metformin, turmeric, and combination groups. The dose of metformin and turmeric were given, respectively, 45mg/KgBW/day and 200 mg/KgBW/day. At the same time, the combo group was given a half dose of each. Blood serum was taken to examine the HDL, IL-6, and TNFa levels. The levels of HDL, IL-6, and TNFain diabetic rats that received the combination of metformin and turmeric extract (p<0.05) were the best among all the groups. It indicated that the combination of metformin and turmeric was better in increasing HDL and reducing IL-6 and TNFa levels better than metformin or turmeric extract alone.
References
Shaw NCJ, Karuranga S, Huang Y, Fernandes J da R, Ohlrogge A, Malanda B. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes research and clinical practice. 2018 Apr 1. 138:271-81.
Hasdianah. Mengenal Diabetes Melitus Pada Orang Dewasa dan Anak-Anak dengan Solusi Herbal Edisi 1. Yogyakarta: Nuha Medika; 2012.
Gillies N, Pendharkar S, Asrani V, Mathew J, Windsor J, Petrov M. Interleukin-6 is associated with chronic hyperglycemia and insulin resistance in patients after acute pancreatitis. Pancreatology. 2016;16(5):748–55. https://doi.org/10.1016/j.pan.2016.06.661
Panahi Y, Hosseini MS, Khalili N, Naimi E, Majeed M, Sahebkar A. Antioxidant and anti-inflammatory effects of curcuminoid-piperine combination in subjects with metabolic syndrome: A randomized controlled trial and an updated meta-analysis. Clin Nutr. 2015;34(6):1101–8. http://dx.doi.org/10.1016/j.clnu.2014.12.019
Rena G, Hardie DG, Pearson ER. The mechanisms of action of metformin. Diabetologia. 2017;60(9):1577–85. https://doi.org/10.1007/s00125-017-4342-z
Su L qing, Wang Y di, Chi H yan. Effect of curcumin on glucose and lipid metabolism, FFAs and TNF-α in serum of type 2 diabetes mellitus rat models. Saudi J Biol Sci. 2017;24(8):1776–80. https://doi.org/10.1016/j.sjbs.2017.11.011
Gutierres VO, Pinheiro CM, Assis RP, Vendramini RC, Pepato MT, Brunetti IL. Curcumin-supplemented yoghurt improves physiological and biochemical markers of experimental diabetes. Br J Nutr. 2012;108(3):440–8. https://doi.org/10.1017/S0007114511005769
Nicol LM, Rowlands DS, Fazakerly R, Kellett J. Curcumin supplementation likely attenuates delayed onset muscle soreness (DOMS). Eur J Appl Physiol. 2015;115(8):1769–77. https://doi.org/10.1007/s00421-015-3152-6
Szkudelski T. Streptozotocin-nicotinamide-induced diabetes in the rat. Characteristics of the experimental model. Exp Biol Med. 2012;237(5):481–90. https://doi.org/10.1258/ebm.2012.011372
Kim M, Kim C, Song Y, Hwang J. Antihyperglycemic and anti-inflammatory effects of standardized curcuma xanthorrhiza roxb. extract and its active compound xanthorrhizol in high-fat diet-induced obese mice. Evid Based Complement Altern Med. 2014;(1):1–10. https://doi.org/10.1155/2014/205915
Zingg J, Hasan S, M. MM. Molecular mechanisms of hypolipidemic effects of curcumin. Biofactors. 2013;39(1):101–21. https://doi.org/10.1002/biof.1072
Hafiane A, Gasbarrino K, Daskalopoulou S. The role of adiponectin in cholesterol efflux and HDL biogenesis and metabolism. Metabolism. 2019;100. https://doi.org/10.1016/j.metabol.2019.153953
Awad A, Al E. Macrophage-Derived Tumor Necrosis Factor-Α Mediates Diabetic Renal Injury‟, Kidney International. Nat Publ Gr. 2015;88(4):722–733. https://doi.org/10.1038/ki.2015.162
Aukunuru J, Joginapally S, Gaddam N, Burra M, Bonepally C., Prabhakar K. Preparation, characterization and evaluation of hepatoprotective activity of an intravenous liposomal formulation of bis-demethoxy curcumin analogue (BDMCA). Int J Drug Dev Res. 2009;1:37–46.
Jain SK, Rains J, Croad J, Larson B, Jones K. Curcumin supplementation lowers TNF-α, IL-6, IL-8, and MCP-1 secretion in high glucose-treated cultured monocytes and blood levels of TNF-α, IL-6, MCP-1, glucose, and glycosylated hemoglobin in diabetic rats. Antioxidants Redox Signal. 2009;11(2):241–9. https://doi.org/10.1089/ars.2008.2140
Schultze SM, Hemmings BA, Niessen M, Tschopp O. PI3K/AKT, MAPK and AMPK signalling: Protein kinases in glucose homeostasis. Expert Rev Mol Med. 2012;14. https://doi.org/10.1017/S1462399411002109
Júnior ASS, Aidar FJ, Santos JL Dos, Estevam CDS, Dos Santos JDM, De Oliveira E Silva AM. Effects of resistance training and turmeric supplementation on reactive species marker stress in diabetic rats. BMC Sports Science Medical Rehabilitation. 2020;12(1):1–12. https://doi.org/10.1186/s13102-020-00194-9
Abdollahi E, Momtazi AA, Johnston TP, Sahebkar A. Therapeutic effects of curcumin in inflammatory and immune-mediated diseases: A nature-made jack-of-all-trades? Vol. 233. Journal of Cellular Physiology. 2018. 830–848 p. https://doi.org/10.1002/jcp.25778
Roxo DF, Arcaro CA, Gutierres VO, Costa MC, Oliveira JO, Lima TFO. Curcumin combined with metformin decreases glycemia and dyslipidemia, and increases paraoxonase activity in diabetic rats. Diabetology Metabolic Syndrome. 2019;11(1):1–8. https://doi.org/10.1186/s13098-019-0431-0
Cao L, Zhi D, Han J, Kumar Sah S, Xie Y. Combinational effect of curcumin and metformin against gentamicin-induced nephrotoxicity: Involvement of antioxidative, anti-inflammatory and antiapoptotic pathway. Journal of Food Biochemistry. 2019;43(7):1–9. https://doi.org/10.1111/jfbc.12836
Downloads
Additional Files
Published
Issue
Section
License
Copyright
Authors retain copyright and grant Mutiara Medika: Jurnal Kedokteran dan Kesehatan (MMJKK) the right of first publication with the work simultaneously licensed under an Attribution 4.0 International (CC BY 4.0) that allows others to remix, adapt and build upon the work with an acknowledgment of the work's authorship and of the initial publication in Mutiara Medika: Jurnal Kedokteran dan Kesehatan (MMJKK).
Authors are permitted to copy and redistribute the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in Mutiara Medika: Jurnal Kedokteran dan Kesehatan (MMJKK).
License
Articles published in the Mutiara Medika: Jurnal Kedokteran dan Kesehatan (MMJKK) are licensed under an Attribution 4.0 International (CC BY 4.0) license. You are free to:
- Share — copy and redistribute the material in any medium or format.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
This license is acceptable for Free Cultural Works. The licensor cannot revoke these freedoms as long as you follow the license terms. Under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
